According to the Zhitong Finance App, Hongri Pharmaceutical (300026.SZ) released its 2026 semi-annual report. During the reporting period, the company achieved revenue of 2.148 billion yuan, a year-on-year decrease of 21.72%. Net profit attributable to shareholders of listed companies was 78.0889 million yuan, a year-on-year decrease of 0.69%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 807.153 million yuan, an increase of 16.67% over the previous year.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.